WallStreetZenWallStreetZen

NASDAQ: TALK
Talkspace Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$2.67-0.06 (-2.2%)
Updated Apr 17, 2025
TALK Price
$2.67
Fair Value Price
N/A
Market Cap
$449.73M
52 Week Low
$1.60
52 Week High
$4.36
P/E
267x
P/B
3.83x
P/S
2.78x
PEG
0.58x
Dividend Yield
N/A
Revenue
$187.59M
Earnings
$1.15M
Gross Margin
45.8%
Operating Margin
-2.4%
Profit Margin
0.6%
Debt to Equity
0.18
Operating Cash Flow
$12M
Beta
0.79
Next Earnings
May 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A

TALK Overview

Talkspace Incorporated delivers virtual behavior healthcare through a web and mobile platform. Treatment options cover every need including psychiatry, and adolescent, individual, and couples therapy. Therapy is provided by a network of licensed therapists by way of chat/email messages, videos, voice messages, live videoconference sessions. The company was founded 2011 and is headquartered in New York, NY.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TALK's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
B
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
B
TALK
Ranked#15 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Nutex Health (NUTX)
$149.00A
Ge Healthcare Technologies (GEHC)
$62.37A
Carecloud (CCLD)
$1.42B
View Top Health Information Service Stocks

Be the first to know about important TALK news, forecast changes, insider trades & much more!

TALK News

Overview

Due Diligence Score

–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TALK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TALK ($2.67) is trading above its intrinsic value of $1.65, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TALK is poor value based on its earnings relative to its share price (267x), compared to the US market average (27.98x)
P/E vs Market Valuation
TALK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more TALK due diligence checks available for Premium users.

Valuation

TALK price to earnings (PE)

For valuing profitable companies with steady earnings

Company
267x
Industry
11.14x
Market
27.98x
TALK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TALK is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

TALK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.83x
Industry
3.39x
TALK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TALK price to earnings growth (PEG)

For valuing profitable companies with growth potential

TALK is good value based... subscribe to Premium to read more.
PEG Value Valuation

TALK's financial health

Profit margin

Revenue
$48.7M
Net Income
$1.2M
Profit Margin
2.5%
TALK's Earnings (EBIT) of -$4.50M... subscribe to Premium to read more.
Interest Coverage Financials
TALK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$138.7M
Liabilities
$21.3M
Debt to equity
0.18
TALK's short-term assets ($130.18M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TALK's short-term assets ($130.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TALK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TALK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.1M
Investing
-$42.9M
Financing
-$3.5M
TALK's operating cash flow ($11.70M)... subscribe to Premium to read more.
Debt Coverage Financials

TALK vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TALKC$449.73M-2.20%267.00x3.83x
DHC$385.45M0.00%-0.71x0.87x
TBRGB$361.49M+0.75%-17.62x2.14x
CTEVD$325.26M-1.18%-0.20x3.87x
SPOKB$319.97M+1.69%21.18x2.07x
View Top Health Information Service Stocks

Talkspace Stock FAQ

What is Talkspace's quote symbol?

(NASDAQ: TALK) Talkspace trades on the NASDAQ under the ticker symbol TALK. Talkspace stock quotes can also be displayed as NASDAQ: TALK.

If you're new to stock investing, here's how to buy Talkspace stock.

What is the 52 week high and low for Talkspace (NASDAQ: TALK)?

(NASDAQ: TALK) Talkspace's 52-week high was $4.36, and its 52-week low was $1.60. It is currently -38.69% from its 52-week high and 66.88% from its 52-week low.

How much is Talkspace stock worth today?

(NASDAQ: TALK) Talkspace currently has 168,437,252 outstanding shares. With Talkspace stock trading at $2.67 per share, the total value of Talkspace stock (market capitalization) is $449.73M.

Talkspace stock was originally listed at a price of $10.25 in Jun 9, 2020. If you had invested in Talkspace stock at $10.25, your return over the last 4 years would have been -73.95%, for an annualized return of -28.56% (not including any dividends or dividend reinvestments).

How much is Talkspace's stock price per share?

(NASDAQ: TALK) Talkspace stock price per share is $2.67 today (as of Apr 17, 2025).

What is Talkspace's Market Cap?

(NASDAQ: TALK) Talkspace's market cap is $449.73M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Talkspace's market cap is calculated by multiplying TALK's current stock price of $2.67 by TALK's total outstanding shares of 168,437,252.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.